Joshua Reed | Chief Financial Officer |
Todd Brady | President & Chief Executive Officer |
Justin Kim | Oppenheimer |
Kelly Shi | Jefferies |
Marc Goodman | SVB Leerink |
Edwin Zhang | H.C. Wainwright |
Esther Hong | Berenberg |
Prakhar Agrawal | JonesTrading |
Yale Jen | Laidlaw & Company |
Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therapeutics First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. I would now like to hand the conference over to the company's Chief Financial Officer, Joshua Reed. Please go ahead, sir.